[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Subdermal Contraceptive Implants Market Growth 2023-2029

March 2023 | 78 pages | ID: G0E29AFBD7A0EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Subdermal contraceptive implants involve the delivery of a steroid progestin from polymer capsules or rods placed under the skin. The hormone diffuses out slowly at a stable rate, providing contraceptive effectiveness for 1-5 years. The period of protection depends upon the specific progestin and the type of polymer.

LPI (LP Information)' newest research report, the “Subdermal Contraceptive Implants Industry Forecast” looks at past sales and reviews total world Subdermal Contraceptive Implants sales in 2022, providing a comprehensive analysis by region and market sector of projected Subdermal Contraceptive Implants sales for 2023 through 2029. With Subdermal Contraceptive Implants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subdermal Contraceptive Implants industry.

This Insight Report provides a comprehensive analysis of the global Subdermal Contraceptive Implants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subdermal Contraceptive Implants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Subdermal Contraceptive Implants market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subdermal Contraceptive Implants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subdermal Contraceptive Implants.

The global Subdermal Contraceptive Implants market size is projected to grow from US$ 635.8 million in 2022 to US$ 984.3 million in 2029; it is expected to grow at a CAGR of 984.3 from 2023 to 2029.

United States market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Subdermal Contraceptive Implants is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Subdermal Contraceptive Implants players cover Bayer AG, Merck and Shanghai Dahua Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Subdermal Contraceptive Implants market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Jadelle
  • Sino-implant
  • Implanon
  • Nexplanon
Segmentation by application
  • Hospitals
  • Clinics
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Bayer AG
  • Merck
  • Shanghai Dahua Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report

What is the 10-year outlook for the global Subdermal Contraceptive Implants market?

What factors are driving Subdermal Contraceptive Implants market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Subdermal Contraceptive Implants market opportunities vary by end market size?

How does Subdermal Contraceptive Implants break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Subdermal Contraceptive Implants Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Subdermal Contraceptive Implants by Country/Region, 2018, 2022 & 2029
2.2 Subdermal Contraceptive Implants Segment by Type
  2.2.1 Jadelle
  2.2.2 Sino-implant
  2.2.3 Implanon
  2.2.4 Nexplanon
2.3 Subdermal Contraceptive Implants Sales by Type
  2.3.1 Global Subdermal Contraceptive Implants Sales Market Share by Type (2018-2023)
  2.3.2 Global Subdermal Contraceptive Implants Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Subdermal Contraceptive Implants Sale Price by Type (2018-2023)
2.4 Subdermal Contraceptive Implants Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Subdermal Contraceptive Implants Sales by Application
  2.5.1 Global Subdermal Contraceptive Implants Sale Market Share by Application (2018-2023)
  2.5.2 Global Subdermal Contraceptive Implants Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Subdermal Contraceptive Implants Sale Price by Application (2018-2023)

3 GLOBAL SUBDERMAL CONTRACEPTIVE IMPLANTS BY COMPANY

3.1 Global Subdermal Contraceptive Implants Breakdown Data by Company
  3.1.1 Global Subdermal Contraceptive Implants Annual Sales by Company (2018-2023)
  3.1.2 Global Subdermal Contraceptive Implants Sales Market Share by Company (2018-2023)
3.2 Global Subdermal Contraceptive Implants Annual Revenue by Company (2018-2023)
  3.2.1 Global Subdermal Contraceptive Implants Revenue by Company (2018-2023)
  3.2.2 Global Subdermal Contraceptive Implants Revenue Market Share by Company (2018-2023)
3.3 Global Subdermal Contraceptive Implants Sale Price by Company
3.4 Key Manufacturers Subdermal Contraceptive Implants Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Subdermal Contraceptive Implants Product Location Distribution
  3.4.2 Players Subdermal Contraceptive Implants Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR SUBDERMAL CONTRACEPTIVE IMPLANTS BY GEOGRAPHIC REGION

4.1 World Historic Subdermal Contraceptive Implants Market Size by Geographic Region (2018-2023)
  4.1.1 Global Subdermal Contraceptive Implants Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Subdermal Contraceptive Implants Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Subdermal Contraceptive Implants Market Size by Country/Region (2018-2023)
  4.2.1 Global Subdermal Contraceptive Implants Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Subdermal Contraceptive Implants Annual Revenue by Country/Region (2018-2023)
4.3 Americas Subdermal Contraceptive Implants Sales Growth
4.4 APAC Subdermal Contraceptive Implants Sales Growth
4.5 Europe Subdermal Contraceptive Implants Sales Growth
4.6 Middle East & Africa Subdermal Contraceptive Implants Sales Growth

5 AMERICAS

5.1 Americas Subdermal Contraceptive Implants Sales by Country
  5.1.1 Americas Subdermal Contraceptive Implants Sales by Country (2018-2023)
  5.1.2 Americas Subdermal Contraceptive Implants Revenue by Country (2018-2023)
5.2 Americas Subdermal Contraceptive Implants Sales by Type
5.3 Americas Subdermal Contraceptive Implants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Subdermal Contraceptive Implants Sales by Region
  6.1.1 APAC Subdermal Contraceptive Implants Sales by Region (2018-2023)
  6.1.2 APAC Subdermal Contraceptive Implants Revenue by Region (2018-2023)
6.2 APAC Subdermal Contraceptive Implants Sales by Type
6.3 APAC Subdermal Contraceptive Implants Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Subdermal Contraceptive Implants by Country
  7.1.1 Europe Subdermal Contraceptive Implants Sales by Country (2018-2023)
  7.1.2 Europe Subdermal Contraceptive Implants Revenue by Country (2018-2023)
7.2 Europe Subdermal Contraceptive Implants Sales by Type
7.3 Europe Subdermal Contraceptive Implants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Subdermal Contraceptive Implants by Country
  8.1.1 Middle East & Africa Subdermal Contraceptive Implants Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Subdermal Contraceptive Implants Revenue by Country (2018-2023)
8.2 Middle East & Africa Subdermal Contraceptive Implants Sales by Type
8.3 Middle East & Africa Subdermal Contraceptive Implants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subdermal Contraceptive Implants
10.3 Manufacturing Process Analysis of Subdermal Contraceptive Implants
10.4 Industry Chain Structure of Subdermal Contraceptive Implants

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Subdermal Contraceptive Implants Distributors
11.3 Subdermal Contraceptive Implants Customer

12 WORLD FORECAST REVIEW FOR SUBDERMAL CONTRACEPTIVE IMPLANTS BY GEOGRAPHIC REGION

12.1 Global Subdermal Contraceptive Implants Market Size Forecast by Region
  12.1.1 Global Subdermal Contraceptive Implants Forecast by Region (2024-2029)
  12.1.2 Global Subdermal Contraceptive Implants Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Subdermal Contraceptive Implants Forecast by Type
12.7 Global Subdermal Contraceptive Implants Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Bayer AG
  13.1.1 Bayer AG Company Information
  13.1.2 Bayer AG Subdermal Contraceptive Implants Product Portfolios and Specifications
  13.1.3 Bayer AG Subdermal Contraceptive Implants Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Bayer AG Main Business Overview
  13.1.5 Bayer AG Latest Developments
13.2 Merck
  13.2.1 Merck Company Information
  13.2.2 Merck Subdermal Contraceptive Implants Product Portfolios and Specifications
  13.2.3 Merck Subdermal Contraceptive Implants Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Merck Main Business Overview
  13.2.5 Merck Latest Developments
13.3 Shanghai Dahua Pharmaceutical Co., Ltd.
  13.3.1 Shanghai Dahua Pharmaceutical Co., Ltd. Company Information
  13.3.2 Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Product Portfolios and Specifications
  13.3.3 Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Shanghai Dahua Pharmaceutical Co., Ltd. Main Business Overview
  13.3.5 Shanghai Dahua Pharmaceutical Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Subdermal Contraceptive Implants Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Subdermal Contraceptive Implants Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Jadelle
Table 4. Major Players of Sino-implant
Table 5. Major Players of Implanon
Table 6. Major Players of Nexplanon
Table 7. Global Subdermal Contraceptive Implants Sales by Type (2018-2023) & (K Units)
Table 8. Global Subdermal Contraceptive Implants Sales Market Share by Type (2018-2023)
Table 9. Global Subdermal Contraceptive Implants Revenue by Type (2018-2023) & ($ million)
Table 10. Global Subdermal Contraceptive Implants Revenue Market Share by Type (2018-2023)
Table 11. Global Subdermal Contraceptive Implants Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Subdermal Contraceptive Implants Sales by Application (2018-2023) & (K Units)
Table 13. Global Subdermal Contraceptive Implants Sales Market Share by Application (2018-2023)
Table 14. Global Subdermal Contraceptive Implants Revenue by Application (2018-2023)
Table 15. Global Subdermal Contraceptive Implants Revenue Market Share by Application (2018-2023)
Table 16. Global Subdermal Contraceptive Implants Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Subdermal Contraceptive Implants Sales by Company (2018-2023) & (K Units)
Table 18. Global Subdermal Contraceptive Implants Sales Market Share by Company (2018-2023)
Table 19. Global Subdermal Contraceptive Implants Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Subdermal Contraceptive Implants Revenue Market Share by Company (2018-2023)
Table 21. Global Subdermal Contraceptive Implants Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Subdermal Contraceptive Implants Producing Area Distribution and Sales Area
Table 23. Players Subdermal Contraceptive Implants Products Offered
Table 24. Subdermal Contraceptive Implants Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Subdermal Contraceptive Implants Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Subdermal Contraceptive Implants Sales Market Share Geographic Region (2018-2023)
Table 29. Global Subdermal Contraceptive Implants Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Subdermal Contraceptive Implants Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Subdermal Contraceptive Implants Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Subdermal Contraceptive Implants Sales Market Share by Country/Region (2018-2023)
Table 33. Global Subdermal Contraceptive Implants Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Subdermal Contraceptive Implants Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Subdermal Contraceptive Implants Sales by Country (2018-2023) & (K Units)
Table 36. Americas Subdermal Contraceptive Implants Sales Market Share by Country (2018-2023)
Table 37. Americas Subdermal Contraceptive Implants Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Subdermal Contraceptive Implants Revenue Market Share by Country (2018-2023)
Table 39. Americas Subdermal Contraceptive Implants Sales by Type (2018-2023) & (K Units)
Table 40. Americas Subdermal Contraceptive Implants Sales by Application (2018-2023) & (K Units)
Table 41. APAC Subdermal Contraceptive Implants Sales by Region (2018-2023) & (K Units)
Table 42. APAC Subdermal Contraceptive Implants Sales Market Share by Region (2018-2023)
Table 43. APAC Subdermal Contraceptive Implants Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Subdermal Contraceptive Implants Revenue Market Share by Region (2018-2023)
Table 45. APAC Subdermal Contraceptive Implants Sales by Type (2018-2023) & (K Units)
Table 46. APAC Subdermal Contraceptive Implants Sales by Application (2018-2023) & (K Units)
Table 47. Europe Subdermal Contraceptive Implants Sales by Country (2018-2023) & (K Units)
Table 48. Europe Subdermal Contraceptive Implants Sales Market Share by Country (2018-2023)
Table 49. Europe Subdermal Contraceptive Implants Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Subdermal Contraceptive Implants Revenue Market Share by Country (2018-2023)
Table 51. Europe Subdermal Contraceptive Implants Sales by Type (2018-2023) & (K Units)
Table 52. Europe Subdermal Contraceptive Implants Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Subdermal Contraceptive Implants Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Subdermal Contraceptive Implants Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Subdermal Contraceptive Implants Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Subdermal Contraceptive Implants Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Subdermal Contraceptive Implants Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Subdermal Contraceptive Implants Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Subdermal Contraceptive Implants
Table 60. Key Market Challenges & Risks of Subdermal Contraceptive Implants
Table 61. Key Industry Trends of Subdermal Contraceptive Implants
Table 62. Subdermal Contraceptive Implants Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Subdermal Contraceptive Implants Distributors List
Table 65. Subdermal Contraceptive Implants Customer List
Table 66. Global Subdermal Contraceptive Implants Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Subdermal Contraceptive Implants Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Subdermal Contraceptive Implants Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Subdermal Contraceptive Implants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Subdermal Contraceptive Implants Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Subdermal Contraceptive Implants Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Subdermal Contraceptive Implants Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Subdermal Contraceptive Implants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Subdermal Contraceptive Implants Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Subdermal Contraceptive Implants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Subdermal Contraceptive Implants Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Subdermal Contraceptive Implants Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Subdermal Contraceptive Implants Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Subdermal Contraceptive Implants Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Bayer AG Basic Information, Subdermal Contraceptive Implants Manufacturing Base, Sales Area and Its Competitors
Table 81. Bayer AG Subdermal Contraceptive Implants Product Portfolios and Specifications
Table 82. Bayer AG Subdermal Contraceptive Implants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Bayer AG Main Business
Table 84. Bayer AG Latest Developments
Table 85. Merck Basic Information, Subdermal Contraceptive Implants Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck Subdermal Contraceptive Implants Product Portfolios and Specifications
Table 87. Merck Subdermal Contraceptive Implants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Shanghai Dahua Pharmaceutical Co., Ltd. Basic Information, Subdermal Contraceptive Implants Manufacturing Base, Sales Area and Its Competitors
Table 91. Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Product Portfolios and Specifications
Table 92. Shanghai Dahua Pharmaceutical Co., Ltd. Subdermal Contraceptive Implants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Shanghai Dahua Pharmaceutical Co., Ltd. Main Business
Table 94. Shanghai Dahua Pharmaceutical Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Subdermal Contraceptive Implants
Figure 2. Subdermal Contraceptive Implants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Subdermal Contraceptive Implants Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Subdermal Contraceptive Implants Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Subdermal Contraceptive Implants Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Jadelle
Figure 10. Product Picture of Sino-implant
Figure 11. Product Picture of Implanon
Figure 12. Product Picture of Nexplanon
Figure 13. Global Subdermal Contraceptive Implants Sales Market Share by Type in 2022
Figure 14. Global Subdermal Contraceptive Implants Revenue Market Share by Type (2018-2023)
Figure 15. Subdermal Contraceptive Implants Consumed in Hospitals
Figure 16. Global Subdermal Contraceptive Implants Market: Hospitals (2018-2023) & (K Units)
Figure 17. Subdermal Contraceptive Implants Consumed in Clinics
Figure 18. Global Subdermal Contraceptive Implants Market: Clinics (2018-2023) & (K Units)
Figure 19. Subdermal Contraceptive Implants Consumed in Others
Figure 20. Global Subdermal Contraceptive Implants Market: Others (2018-2023) & (K Units)
Figure 21. Global Subdermal Contraceptive Implants Sales Market Share by Application (2022)
Figure 22. Global Subdermal Contraceptive Implants Revenue Market Share by Application in 2022
Figure 23. Subdermal Contraceptive Implants Sales Market by Company in 2022 (K Units)
Figure 24. Global Subdermal Contraceptive Implants Sales Market Share by Company in 2022
Figure 25. Subdermal Contraceptive Implants Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Subdermal Contraceptive Implants Revenue Market Share by Company in 2022
Figure 27. Global Subdermal Contraceptive Implants Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Subdermal Contraceptive Implants Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Subdermal Contraceptive Implants Sales 2018-2023 (K Units)
Figure 30. Americas Subdermal Contraceptive Implants Revenue 2018-2023 ($ Millions)
Figure 31. APAC Subdermal Contraceptive Implants Sales 2018-2023 (K Units)
Figure 32. APAC Subdermal Contraceptive Implants Revenue 2018-2023 ($ Millions)
Figure 33. Europe Subdermal Contraceptive Implants Sales 2018-2023 (K Units)
Figure 34. Europe Subdermal Contraceptive Implants Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Subdermal Contraceptive Implants Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Subdermal Contraceptive Implants Revenue 2018-2023 ($ Millions)
Figure 37. Americas Subdermal Contraceptive Implants Sales Market Share by Country in 2022
Figure 38. Americas Subdermal Contraceptive Implants Revenue Market Share by Country in 2022
Figure 39. Americas Subdermal Contraceptive Implants Sales Market Share by Type (2018-2023)
Figure 40. Americas Subdermal Contraceptive Implants Sales Market Share by Application (2018-2023)
Figure 41. United States Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Subdermal Contraceptive Implants Sales Market Share by Region in 2022
Figure 46. APAC Subdermal Contraceptive Implants Revenue Market Share by Regions in 2022
Figure 47. APAC Subdermal Contraceptive Implants Sales Market Share by Type (2018-2023)
Figure 48. APAC Subdermal Contraceptive Implants Sales Market Share by Application (2018-2023)
Figure 49. China Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Subdermal Contraceptive Implants Sales Market Share by Country in 2022
Figure 57. Europe Subdermal Contraceptive Implants Revenue Market Share by Country in 2022
Figure 58. Europe Subdermal Contraceptive Implants Sales Market Share by Type (2018-2023)
Figure 59. Europe Subdermal Contraceptive Implants Sales Market Share by Application (2018-2023)
Figure 60. Germany Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Subdermal Contraceptive Implants Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Subdermal Contraceptive Implants Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Subdermal Contraceptive Implants Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Subdermal Contraceptive Implants Sales Market Share by Application (2018-2023)
Figure 69. Egypt Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Subdermal Contraceptive Implants Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Subdermal Contraceptive Implants in 2022
Figure 75. Manufacturing Process Analysis of Subdermal Contraceptive Implants
Figure 76. Industry Chain Structure of Subdermal Contraceptive Implants
Figure 77. Channels of Distribution
Figure 78. Global Subdermal Contraceptive Implants Sales Market Forecast by Region (2024-2029)
Figure 79. Global Subdermal Contraceptive Implants Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Subdermal Contraceptive Implants Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Subdermal Contraceptive Implants Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Subdermal Contraceptive Implants Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Subdermal Contraceptive Implants Revenue Market Share Forecast by Application (2024-2029)


More Publications